Champions Oncology, Inc. engages in the development and sale of technology solutions and products to personalize the development and use of oncology drugs. Its technology platform, TumorGraft, is a novel approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company was founded by James M. Martell and David Sidransky on June 4, 1985 and is headquartered in Hackensack, NJ.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
214
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Champions Oncology Inc market cap is $65.49M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Champions Oncology Inc 52 week high is $8.31 as of November 17, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Champions Oncology Inc 52 week low is $4.52 as of November 17, 2026.
Champions Oncology Inc stock price today is $4.68.
Champions Oncology Inc stock price yesterday was $4.71.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Champions Oncology Inc's P/E ratio is -58.35.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Champions Oncology Inc P/B ratio is 16.7322.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Champions Oncology Inc 50-day moving average is $4.89.